Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)

Details for Australian Patent Application No. 2008259976 (hide)

International Classifications

Event Publications

7 January 2010 PCT application entered the National Phase

PCT publication WO2008/151035 Priority application(s): WO2008/151035

24 November 2011 Assignment before Grant

Nevada Cancer Institute The application has been assigned to Yupo Ma Assignments before Grant, Section 113

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.